Prognostic significance of end-of-induction measurable residual disease below 0.01% in pediatric B-lineage acute lymphoblastic leukemia.
End-of-induction measurable residual disease (EOI-MRD) predicts poor outcomes in B-lineage acute lymphoblastic leukemia (B-ALL). While MRD positivity is conventionally defined at ≥0.01%, data regarding the prognostic relevance of flow cytometry derived EOI-MRD of <0.01% are emerging. Consecutive pediatric B-ALL patient...